Welcome to LookChem.com Sign In|Join Free

CAS

  • or

936845-86-2

Post Buying Request

936845-86-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • tert-butyl 4-[6-[(5-ethenyl-1,3-thiazol-2-yl)amino]-2-methylpyrimidin-4-yl]piperazine-1-carboxylate

    Cas No: 936845-86-2

  • No Data

  • No Data

  • No Data

  • Chemlyte Solutions
  • Contact Supplier

936845-86-2 Usage

General Description

1-Piperazinecarboxylic acid, 4-[6-[(5-ethenyl-2-thiazolyl)amino]-2-methyl-4-pyrimidinyl]-, 1,1-dimethylethyl ester is a chemical compound with potential pharmacological uses. It is a derivative of piperazinecarboxylic acid and is related to thiazole and pyrimidine. The 1,1-dimethylethyl ester group is often used to enhance the bioavailability and stability of drugs. 1-Piperazinecarboxylic acid, 4-[6-[(5-ethenyl-2-thiazolyl)amino]-2-methyl-4-pyrimidinyl]-, 1,1-dimethylethyl ester may have application in the development of pharmaceuticals targeting specific biological pathways or disorders. Further research is necessary to determine its exact mechanism of action and potential therapeutic uses.

Check Digit Verification of cas no

The CAS Registry Mumber 936845-86-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,3,6,8,4 and 5 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 936845-86:
(8*9)+(7*3)+(6*6)+(5*8)+(4*4)+(3*5)+(2*8)+(1*6)=222
222 % 10 = 2
So 936845-86-2 is a valid CAS Registry Number.

936845-86-2Relevant articles and documents

THIAZOLE INHIBITORS TARGETING RESISTANT AND KINASE MUTATIONS

-

Page/Page column 49-50, (2010/11/27)

A compound is provided, having the general structure (A): wherein A is an aryl or heteroaryl group, Y is a hydrophobic linking moiety, and L is a substitutent. The compound (A) can be used for treatment of various angiogenic-associated or hematologic disorders, such as myeloproliferative disorders in patients who do not respond to kinase-inhibition therapy that comprises administering currently used medications.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 936845-86-2